The 14-year incidence of visual loss in a diabetic population

Ophthalmology

Volumn 105, Issue 6, 1998, Pages 998-1003

  Moss, Scot E ^a,b   Klein, Ronald ^a   Klein, Barbara E K ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; AGING; ARTICLE; BLINDNESS; BLOOD PRESSURE; DIABETES MELLITUS; DIABETIC RETINOPATHY; DISEASE DURATION; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEINURIA; RISK FACTOR; SMOKING; VISUAL IMPAIRMENT;

EID: 0031807908     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(98)96025-0     Document Type: Article

References (27)

1. The Diabetic Retinopathy Study Research Group. Preliminary report on effects of photocoagulation therapy. Am J Ophthalmol 1976;81:383-96.
2. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol 1985;103:1796-806.
3. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
4. Ferris FL III. How effective are treatments for diabetic retinopathy? JAMA 1993;269:1290-1.
5. American College of Physicians, American Diabetes Association, and American Academy of Ophthalmology. Screening guidelines for diabetic retinopathy. Ann Intern Med 1992;116:683-5.
6. National Institutes of Health. The National Eye Health Education Program: From Vision Research to Eye Health Education: Planning the Partnership. Bethesda, MD, NIH, March 1990.
7. Klein R, Klein BEK, Moss SE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984;102:520-6.
8. Klein R, Klein BEK, Moss SE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1989; 107:237-43.
9. Klein R, Klein BEK, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol 1994;112:1217-28.
10. Klein R, Klein BEK, Moss SE. Visual impairment in diabetes. Ophthalmology 1984;91:1-9.
11. Moss SE, Klein R, Klein BEK. The incidence of vision loss in a diabetic population. Ophthalmology 1988;95:1340-8.
12. Moss SE, Klein R, Klein BEK. Ten-year incidence of visual loss in a diabetic population. Ophthalmology 1994;101: 1061-70.
13. Early Treatment Diabetic Retinopathy Study. Manual of Operations. Chap. 12. Available from the National Technical Information Service (Accession #PB85223006).
14. Diabetic Retinopathy Study Research Group. Report 7. A modification of the Airlie House classification of diabetic retinopathy. Invest Ophthalmol Vis Sci 1981;21:210-26.
15. Klein R, Klein BEK, Moss SE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IV. Diabetic macular edema. Ophthalmology 1984;91:1464-74.
16. Moss SE, Klein R, Klein BEK, et al. Methodologic considerations in measuring glycosylated hemoglobin in epidemiologic studies. J Clin Epidemiol 1988;41:645-9.
17. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
18. Mantel N. Chi-square tests with one degree of freedom. Extensions of the Mantel-Haenszel procedure. J Am Stat Assoc 1963;58:690-700.
19. Hosmer DW Jr, Lemeshow S. Applied Logistic Regression. New York: Wiley, 1989;238-45.
20. Sjolie AK, Green A. Blindness in insulin-treated diabetic patients with age at onset <30 years. J Chronic Dis 1987;40:215-20.
21. Agardh E, Agardh C-D, Hansson-Lundblad C. The five-year incidence of blindness after introducing a screening program for early detection of treatable diabetic retinopathy. Diabet Med 1992;10:555-9.
22. Henricsson M, Tyrberg M, Heijl A, Janzon L. Incidence of blindness and visual impairment in diabetic patients participating in an ophthalmological control and screening programme. Acta Ophthalmol Scand 1996;74:533-8.
23. Trautner C, Icks A, Haastert B, et al. Incidence of blindness in relation to diabetes. A population-based study. Diabetes Care 1997;20:1147-53.
24. Deckert T, Simonsen SE, Poulsen JE. Prognosis of proliferative retinopathy in juvenile diabetics. Diabetes 1967; 16:728-33.
25. Rand LI, Prud'homme GJ, Ederer F, Canner PL. Factors influencing the development of visual loss in advanced diabetic retinopathy. Diabetic Retinopathy Study (DRS) report no. 10. Invest Ophthalmol Vis Sci 1985;26:983-91.
26. Nielsen NV. Diabetic retinopathy I. The course of retinopathy in insulin-treated diabetics. A one year epidemiological cohort study of diabetes mellitus. The Island of Falster, Denmark. Acta Ophthalmol 1984;62:256-65.
27. Reichard P. Are there any glycemic thresholds for the serious microvascular diabetic complications? J Diabetes Complications 1995;9:25-30.